Modulation of hemodynamic effects with a converting enzyme inhibitor: Acute hemodynamic dose-response relationship of a new angiotensin converting enzyme inhibitor, lisinopril, with observations on long-term clinical, functional, and biochemical responses
- 31 August 1988
- journal article
- clinical trial
- Published by Elsevier BV in American Heart Journal
- Vol. 116 (2), 480-488
- https://doi.org/10.1016/0002-8703(88)90621-7
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Hemodynamic, Hormonal, and Pharmacokinetic Aspects of Treatment with Lisinopril in Congestive Heart FailureJournal of Cardiovascular Pharmacology, 1987
- EnalaprilDrugs, 1986
- Effects of enalapril, a new angiotensin-converting enzyme inhibitor, in a controlled trial in heart failureJournal of the American College of Cardiology, 1985
- Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study.Cell Metabolism, 1984
- Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.British Journal of Clinical Pharmacology, 1984
- A placebo-controlled trial of captopril in refractory chronic congestive heart failureJournal of the American College of Cardiology, 1983
- Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study.Circulation, 1983
- Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.British Journal of Clinical Pharmacology, 1982
- An Algorithm for Least-Squares Estimation of Nonlinear ParametersJournal of the Society for Industrial and Applied Mathematics, 1963
- A DISTRIBUTION-FREE k-SAMPLE TEST AGAINST ORDERED ALTERNATIVESBiometrika, 1954